Our understanding of AD has long been informed by early studies characterising dysregulated amyloid precursor protein (APP) processing, leading to the formation of amyloid beta (Aβ) plaques and tau tangles, resulting in neuronal atrophy [72]. The gene discussed is MAPT; the disease is Alzheimer disease.